OrthoPediatrics Corp.
NASDAQ:KIDSMedical - Devices
+$0.19 today
- Market cap
- $826.40M
- Beta
- 1.01
- P/E (TTM)
- -11.0
- EPS (TTM)
- -$1.68
Volume 0.16M
Average 0.16M
KIDS Capital Expenditures
Cash spent on property, plant, equipment, and other long-term assets.
OrthoPediatrics Corp.NASDAQ: KIDS
Capital Expenditures · Q1 FY2026 · quarter ended Mar 2026
Capital expenditures declines year over year
Q1 FY2026 capital expenditures of $1.76M (cash outflow) fell 58.4% year over year, behind the -28.2% change in trailing-twelve-month capital expenditures. Sequentially, it rose 193.8% from the prior quarter. Over 3 fiscal years it compounded at +3.5% a year.
Context
- Capital expenditures amounted to 4.7% of revenue in FY2025, down 2.3 pp from a year earlier.
- Capital expenditures grew in size in 1 of the last 3 fiscal years.
What to watch
Whether quarterly growth recovers from -58.4% toward the trailing-twelve-month pace of -28.2%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Capital Expenditures history
USD · from the cash flow
- Latest · FY2025
- (11.11M) USD
- Year-over-year change
- +22.1%
| Period | Period end | Capital Expenditures | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (11.11M) | +22.1% |
| FY2024 | 2024-12-31 | (14.26M) | +24.9% |
| FY2023 | 2023-12-31 | (18.98M) | -89.3% |
| FY2022 | 2022-12-31 | (10.03M) | +37.3% |
| FY2021 | 2021-12-31 | (16.01M) | — |
Capital Expenditures vs competitors
How KIDS compares with its peers on the latest reported figures
- KIDS's LTM Mar 2026 capital expenditures of $8.64M is the 2nd largest of the 8 companies compared; the peer median is $3.91M.
- Its year-over-year change of -28.2% is the 6th highest of 8, against a peer median of -0.8%.
- Capital expenditures amounts to 3.6% of revenue for KIDS, versus a peer median of 1.6%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $13.04M | +16.3% | -3.1% | 6.3% | |
| LTM Mar 2026 | $8.64M | -28.2% | +3.5% | 3.6% | |
| LTM Mar 2026 | $4.74M | -19.5% | +5.4% | 1.6% | |
| LTM Mar 2026 | $4.01M | -0.8% | +17.0% | 3.1% | |
| LTM Mar 2026 | $3.91M | +11.6% | -16.7% | 0.7% | |
| LTM Mar 2026 | $3.82M | -69.8% | +29.5% | 4.4% | |
| LTM Mar 2026 | $2.31M | +49.9% | +20.1% | 0.4% | |
CBLLCeriBell, Inc. | LTM Mar 2026 | $744K | -50.0% | +14.1% | 0.8% |
| Peer median (excluding KIDS) | $3.91M | -0.8% | +14.1% | 1.6% | |
Competitors are the stored peer set for KIDS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (16.26M) | 1.26M | (20.97M) | (37.82M) | (39.65M) |
| Depreciation & Amortization | 10.68M | 13.1M | 17.39M | 19.08M | 21.12M |
| Deferred Income Tax | (1.13M) | (5.03M) | (1.16M) | (4.74M) | (153K) |
| Stock-Based Compensation | 5.84M | 6.68M | 10.53M | 13.55M | 17.78M |
| Change in Working Capital | (12.55M) | (17.76M) | (32.2M) | (22.94M) | (10.79M) |
| Accounts Receivables | (466K) | (3.98M) | (9.72M) | (4.75M) | (9.37M) |
| Inventory | (5.05M) | (16.94M) | (26.28M) | (13.2M) | (8.47M) |
| Accounts Payables | (567K) | (209K) | 1.49M | (4.28M) | 8.17M |
| Other Working Capital | (6.47M) | 3.37M | 2.32M | (709K) | (1.12M) |
| Other Non-Cash Items | 354K | (20.01M) | (623K) | 5.82M | 6.85M |
| Operating Cash Flow | (13.06M) | (21.77M) | (27.05M) | (27.05M) | (4.85M) |
| Capital Expenditures | (16.01M) | (10.03M) | (18.98M) | (14.26M) | (11.11M) |
| Acquisitions (Net) | 0 | (40.09M) | (3.64M) | (20.23M) | (15.5M) |
| Purchases of Investments | 0 | (110.12M) | (48.6M) | (25.65M) | (17.02M) |
| Sales of Investments | 9.25M | 46.87M | 112.9M | 49.86M | 0 |
| Other Investing Activities | (650K) | 0 | (2.11M) | (2.88M) | 0 |
| Investing Cash Flow | (7.41M) | (113.37M) | 41.68M | (13.16M) | (43.63M) |
| Debt Repayment | (131K) | (137K) | 9.28M | 56.54M | 23.98M |
| Common Stock Issued | 137K | 139.28M | 21K | 0 | 0 |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | (3.17M) | (2M) | (3.41M) | 0 |
| Financing Cash Flow | 6K | 135.97M | 7.3M | 53.14M | 23.98M |
| Effect of Forex Changes | (658K) | 619K | 633K | (175K) | 348K |
| Net Change in Cash | (21.13M) | 1.46M | 22.57M | 12.75M | (24.16M) |
| Free Cash Flow | (29.07M) | (31.8M) | (46.03M) | (41.31M) | (15.96M) |
OrthoPediatrics Corp.
NASDAQ:KIDS
Intrinsic Alpha fair value
Locked
Current Price
$31.65
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.